Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristian Tonby

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 30, 2007
[What drug companies actually do]Kristian Tonby
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 24, 2006
[Forgotten diseases and new drugs]Kristian Tonby
Scientific Reports|March 19, 2015
IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infectionKristian Tonby, Morten Ruhwald, Dag Kvale, et al.
The Journal of Infectious Diseases|March 20, 2019
KLRG1-Expressing CD4 T Cells Are Reduced in Tuberculosis Patients Compared to Healthy Mycobacterium tuberculosis-Infected Subjects, but Increase With TreatmentKristian Tonby, Rasmus Mortensen, Morten Ruhwald, et al.
Plos One|November 7, 2015
Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway InhibitorsNora V Lieske, Kristian Tonby, Dag Kvale, et al.
Frontiers in Immunology|December 11, 2020
Elevated Levels of Anti-Inflammatory Eicosanoids and Monocyte Heterogeneity in <i>Mycobacterium tuberculosis</i> Infection and DiseaseKristin Grotle Nore, Marthe Jøntvedt Jørgensen, Anne Ma Dyrhol-Riise, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 23, 2022
We need a new action plan for antibiotic resistanceBjørn Waagsbø, Heidi Johanne Espvik, June Utnes Høgli, et al.
BMC Infectious Diseases|October 26, 2016
The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infectionKristian Tonby, Ida Wergeland, Nora V Lieske, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 6, 2025
[Clostridioides difficile infection]Mari Ims Skåland, Kristian Tonby, André Ingebretsen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 21, 2020
Antibiotic use in hospitals in cases of COVID-19Håkon Kinck Borén, Christian Magnus Thaulow, Else Quist-Paulsen, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 30, 2007
[What drug companies actually do]Kristian Tonby
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 24, 2006
[Forgotten diseases and new drugs]Kristian Tonby
Scientific Reports|March 19, 2015
IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infectionKristian Tonby, Morten Ruhwald, Dag Kvale, et al.
The Journal of Infectious Diseases|March 20, 2019
KLRG1-Expressing CD4 T Cells Are Reduced in Tuberculosis Patients Compared to Healthy Mycobacterium tuberculosis-Infected Subjects, but Increase With TreatmentKristian Tonby, Rasmus Mortensen, Morten Ruhwald, et al.
Plos One|November 7, 2015
Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway InhibitorsNora V Lieske, Kristian Tonby, Dag Kvale, et al.
Frontiers in Immunology|December 11, 2020
Elevated Levels of Anti-Inflammatory Eicosanoids and Monocyte Heterogeneity in <i>Mycobacterium tuberculosis</i> Infection and DiseaseKristin Grotle Nore, Marthe Jøntvedt Jørgensen, Anne Ma Dyrhol-Riise, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 23, 2022
We need a new action plan for antibiotic resistanceBjørn Waagsbø, Heidi Johanne Espvik, June Utnes Høgli, et al.
BMC Infectious Diseases|October 26, 2016
The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infectionKristian Tonby, Ida Wergeland, Nora V Lieske, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 6, 2025
[Clostridioides difficile infection]Mari Ims Skåland, Kristian Tonby, André Ingebretsen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 21, 2020
Antibiotic use in hospitals in cases of COVID-19Håkon Kinck Borén, Christian Magnus Thaulow, Else Quist-Paulsen, et al.
Pageof 6